FDA — authorised 4 April 2002
- Marketing authorisation holder: CHIRHOCLIN
- Status: approved
🇺🇸 Chirhostim in United States
FDA authorised Chirhostim on 4 April 2002
Marketing authorisation
Chirhostim in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Chirhostim approved in United States?
Yes. FDA authorised it on 4 April 2002.
Who is the marketing authorisation holder for Chirhostim in United States?
CHIRHOCLIN holds the US marketing authorisation.